insights_auto
Proč je NCYT níž 3,96%?
Prozkoumat hloubějichevron_right
NCYT:LON
Novacyt SA
38,80 GBX
arrow_downward
-3,96%(-1,60) 1D
12. 10., 16:35:04 GMT+1 · GBX
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro NCYT…
Otevřít
42,16 GBX
Max.
42,16 GBX
Min.
38,60 GBX
Trž. kap.
31,35 mil.
Prům. obj.
100,76 tis.
Objem
255,30 tis.
52týd. max.
86,00 GBX
52týd. min.
26,60 GBX
Akcie v oběhu
37,66 mil.
Počet zaměstnanců
228
Otevřít
42,16 GBX
Max.
42,16 GBX
Min.
38,60 GBX
Trž. kap.
31,35 mil.
Prům. obj.
100,76 tis.
Objem
255,30 tis.
52týd. max.
86,00 GBX
52týd. min.
26,60 GBX
Akcie v oběhu
37,66 mil.
Počet zaměstnanců
228
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
GlobeNewswire
·
před 27 minutami
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Business Journals
·
před 46 minutami
Axe Compute rings Nasdaq bell after pivoting from biotech to AI tokens
CNBC
·
před 1 hodinou
Citi's Scott Chronert on getting the S&P 500 to 8,100: We need both parts of the market performing
Seeking Alpha
·
před 21 minutami
3 things to look out for on Tuesday (SP500:)
Profil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Informace o Novacyt SA